Sensitization by glycerol for CDDP-therapy against human cultured cancer cells and tumors bearing mutated p53 gene

By Yuki K.  

Apoptosis, Vol. 9, Iss. 6, 2004-11 ,pp. : 853-859

Springer Publishing Company

Access to resources Recommend Favorite

Sources of bias in the detection and reporting of p53 mutations in human cancer: analysis of the IARC p53 mutation database

By MaevMaev R.G.   ShaoShao H.   MaevaMaeva E.Y.   Hernandez-Boussard T.   Montesano R.   Hainaut P.  

Genetic Analysis: Biomolecular Engineering, Vol. 14, Iss. 5, 1999-02 ,pp. : 229-233

Elsevier

Access to resources Recommend Favorite

The molecular epidemiology of P53 gene mutations in human breast cancer

By Hartmann A.   Blaszyk H.   Kovach J.S.   Sommer S.S.  

Trends in Genetics, Vol. 13, Iss. 1, 1997-01 ,pp. : 27-33

Elsevier

Access to resources Recommend Favorite

The p53 tumor suppressor: Critical regulator of life & death in cancer

By Fisher D.E.  

Apoptosis, Vol. 6, Iss. 1-2, 2001-02 ,pp. : 7-15

Springer Publishing Company

Access to resources Recommend Favorite

Brefeldin A Is a Potent Inducer of Apoptosis in Human Cancer Cells Independently of p53

By Shao R.-G.   Shimizu T.   Pommier Y.  

Experimental Cell Research, Vol. 227, Iss. 2, 1996-09 ,pp. : 190-196

Elsevier

Access to resources Recommend Favorite